Gynecologic Cancers

BRCA+   

Questions discussed in this category


Does your practice vary based on risk status (low vs high risk) or specific mutation status (BRCA+ vs HRD+) given PAOLA subset analyses? 


Papers discussed in this category


The New England journal of medicine, 2018-12-27

Lancet Oncol, 2021 Mar 18

N Engl J Med, 2019 Dec 19

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-09-10

Lancet Oncol, 2015 Jun 23